Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing ipratropium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ipratropium adverse reaction |
Causative agent (attribute) |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to ipratropium (finding) |
Causative agent (attribute) |
False |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ipratropium bromide (substance) |
Is a |
False |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fenoterol hydrobromide+ipratropium bromide 500micrograms/1.25mg nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fenoterol hydrobromide+ipratropium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ipratropium- and salbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fenoterol and ipratropium (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ipratropium-containing product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ipratropium in respiratory dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to ipratropium (finding) |
Causative agent (attribute) |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ipratropium bromide (substance) |
Is modification of (attribute) |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ipratropium-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ipratropium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ipratropium and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fenoterol and ipratropium only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ipratropium only product in nasal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only ipratropium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
Has precise active ingredient |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely fenoterol 500 microgram and ipratropium 1.25 milligram/1 actuation conventional release solution for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ipratropium and salbutamol only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Fenoterol and ipratropium only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing fenoterol and ipratropium in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing ipratropium and salbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Ipratropium and levosalbutamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Ipratropium- and levosalbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only ipratropium and levosalbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Ipratropium (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |